Drug details

Briviact (brivaracetam oral solution and intravenous injection)

type of Ligands

Briviact (brivaracetam) is an antiepileptic drug (AED) indicated as adjunctive therapy in the treatment of partial-onset seizures in patients 16 years of age and older with epilepsy.

The drug is often used to treat Epilepsy .

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• nausea,
• fever,
• lightheadedness,
• dizziness,
• dry mouth,
• cough,
• noisy breathing,
• restlessness,
• chest pain or pressure,
• fast or shallow breathing,
• mood changes,
• drowsiness,
• irregular heartbeat,
• anxiety,
• trouble sleeping,
• thoughts of self-harm,
• irritability,
• unusual drowsiness,
• spinning sensation,
• difficulty swallowing,
• double vision,
• general feeling of unwellness,
• numbness of feet, hands, and around mouth,
• sleepiness,
• unusually long or deep sleep,
• reddening of the skin, especially around the ears,
• shakiness, and
• poor coordination or muscle control

The following drugs are related to Briviact, either as a replacement or used together:

• Tegretol (carbamazepine)
• Carbatrol (carbamazepine extended-release)
• Diacomit (stiripentol)
• Gabitril (tiagabine hydrochloride)
• Motpoly XR (lacosamide extended-release capsules)
• Lamictal (lamotrigine)
• Lamictal XR (lamotrigine extended-release tablets)
• Mysoline (primidone)
• Qudexy XR (topiramate extended-release capsules)
• Topamax (topiramate)
• Trokendi XR (topiramate extended-release capsules)
• Vigadrone (vigabatrin for oral solution)
• Zonisade (zonisamide oral suspension)